Liver ischemia-reperfusion injury (LIRI) is a pathological process involving multiple injury factors and cell types, with different stages. Currently, protective drugs targeting a single condition are limited in efficacy, and interventions on immune cells will also be accompanied by a series of side effects. In the current bottleneck research stage, the multi-target and obvious clinical efficacy of Chinese medicine (CM) is expected to become a breakthrough point in the research and development of new drugs. In this review, we summarize the roles of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in various stages of hepatic ischemia-reperfusion and on various types of cells. Combined with the current research progress in reducing ROS/RNS with CM, new therapies and mechanisms for the treatment of hepatic ischemia-reperfusion are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11655-024-3810-9DOI Listing

Publication Analysis

Top Keywords

liver ischemia-reperfusion
8
ischemia-reperfusion injury
8
chinese medicine
8
hepatic ischemia-reperfusion
8
mechanism reactive
4
reactive oxygen/nitrogen
4
oxygen/nitrogen species
4
species liver
4
ischemia-reperfusion
4
injury preventive
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!